Galaxy Medicare
add_icon

Galaxy Medicare

20.05
-0.70
(-3.37%)
Market Cap
₹30.42 Cr
PE Ratio
9.35
Volume
20,000.00
Day High - Low
₹21.00 - ₹20.00
52W High-Low
₹54.00 - ₹18.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
30.42 Cr
EPS
2.84
PB Ratio
0.87
Book Value
23.88
EBITDA
5.70
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
13.95
Debt to Equity
0.38
Forecast For
Actual

Company News

View All News
Caret
positive
Galaxy Medicare Limited enters agreement with Odisha government to establish pharmaceutical and medical devices manufacturing unit in Khordha district with proposed investment of ₹19.45 crores.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,796.80
#1 18,206.20
51.78
#1 1,759.00
22.62
#1 339
5.03
35.05
260.40
1,431.21
55.21
242.40
24.12
25
44.07
37.60
230.69
1,227.42
59.08
408.40
32.64
30
-67.96
43.62
221.31
983.74
#1 21.40
335.90
45.66
47
751.52
43.30
546.75
967.45
46.99
186.60
40.62
20
-
30.80
575.00
955.75
64.16
249.37
43.89
17
-14.81
39.64
316.55
602.71
38.32
136.30
#1 107.77
16
-
49.98
490.00
588.10
29.50
67.10
13.15
18
14.58
57.70
290.00
378.07
47.95
111.80
-
8
-
52.27
281.85
281.85
68.69
122.10
19.24
1
#1 820.00
48.13
Growth Rate
Revenue Growth
9.21 %
Net Income Growth
-8.11 %
Cash Flow Change
65.68 %
ROE
-19.55 %
ROCE
-11.89 %
EBITDA Margin (Avg.)
-7.97 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
29
31
32
37
40
0
Expenses
27
27
29
31
35
0
EBITDA
3
3
3
6
6
0
Operating Profit %
7 %
8 %
7 %
14 %
12 %
0 %
Depreciation
1
1
1
1
1
0
Interest
1
1
1
1
1
0
Profit Before Tax
1
0
2
5
5
0
Tax
0
0
0
1
1
0
Net Profit
1
-0
2
4
3
0
EPS in ₹
2.56
-0.70
5.17
3.13
2.84
0.00

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
30
31
32
33
32
Fixed Assets
14
15
14
14
14
Current Assets
13
14
15
15
15
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
0
0
Other Assets
16
16
18
18
17
Total Liabilities
30
31
32
33
32
Current Liabilities
12
11
12
9
7
Non Current Liabilities
2
4
3
2
1
Total Equity
16
16
18
21
24
Reserve & Surplus
13
13
15
10
12
Share Capital
3
3
3
12
12

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
0
0
-0
0
0
Investing Activities
-5
-1
-2
-1
0
Operating Activities
6
-1
4
3
5
Financing Activities
-1
1
-2
-2
-5

Share Holding

% Holding
Mar 2025
Sept 2025
Promoter
99.57 %
72.43 %
FIIs
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
Government
0.00 %
0.00 %
Public / Retail
0.43 %
24.74 %
Others
0.00 %
2.83 %
No of Share Holders
17
17

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 22.00 22.40
10 Dec 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Dec 2025 18.55 19.50
17 Dec 2025 DIVIDEND Dividend
0.35 /share
17 Dec 2025 19.50 22.25

Technical Indicators

RSI(14)
Neutral
46.02
ATR(14)
Volatile
1.24
STOCH(9,6)
Neutral
76.01
STOCH RSI(14)
Overbought
85.16
MACD(12,26)
Bullish
0.49
ADX(14)
Strong Trend
45.03
UO(9)
Bearish
49.31
ROC(12)
Uptrend And Accelerating
11.86
WillR(14)
Neutral
-48.04